HY-42490-100mg
|
MedChemexpress LLC
|
N3-PEG3-CH2CH2COOH [CAS 1056024-94-2]
|
|
COVID-19-immunoregulation
|
|
HY-42490-50mg
|
MedChemexpress LLC
|
N3-PEG3-CH2CH2COOH [CAS 1056024-94-2]
|
|
COVID-19-immunoregulation
|
|
HY-114816-100mg
|
MedChemexpress LLC
|
N-Butanoyl-L-homoserine lactone [CAS 67605-85-0]
|
|
COVID-19-immunoregulation
|
|
HY-114816-50mg
|
MedChemexpress LLC
|
N-Butanoyl-L-homoserine lactone [CAS 67605-85-0]
|
|
COVID-19-immunoregulation
|
|
HY-P99036-1mg
|
MedChemexpress LLC
|
Nesvacumab [CAS 1296818-77-3]
|
|
COVID-19-immunoregulation
|
|
HY-P99036-10mg
|
MedChemexpress LLC
|
Nesvacumab [CAS 1296818-77-3]
|
|
COVID-19-immunoregulation
|
|
HY-P99036-5mg
|
MedChemexpress LLC
|
Nesvacumab [CAS 1296818-77-3]
|
|
COVID-19-immunoregulation
|
|
HY-P99037-1mg
|
MedChemexpress LLC
|
Nipocalimab [CAS 2211985-36-1]
|
|
COVID-19-immunoregulation
|
|
HY-P99037-5mg
|
MedChemexpress LLC
|
Nipocalimab [CAS 2211985-36-1]
|
|
COVID-19-immunoregulation
|
|
HY-P9932-1mg
|
MedChemexpress LLC
|
Obiltoxaximab [CAS 1351337-07-9]
|
|
COVID-19-immunoregulation
|
|
HY-P9932-10mg
|
MedChemexpress LLC
|
Obiltoxaximab [CAS 1351337-07-9]
|
|
COVID-19-immunoregulation
|
|
HY-P9932-5mg
|
MedChemexpress LLC
|
Obiltoxaximab [CAS 1351337-07-9]
|
|
COVID-19-immunoregulation
|
|
HY-P9950-1mg
|
MedChemexpress LLC
|
Omalizumab [CAS 242138-07-4]
|
|
COVID-19-immunoregulation
|
|
HY-P9950-5mg
|
MedChemexpress LLC
|
Omalizumab [CAS 242138-07-4]
|
|
COVID-19-immunoregulation
|
|
HY-P99791-1mg
|
MedChemexpress LLC
|
Orilanolimab [CAS 2066544-85-0]
|
|
COVID-19-immunoregulation
|
|
HY-P99791-10mg
|
MedChemexpress LLC
|
Orilanolimab [CAS 2066544-85-0]
|
|
COVID-19-immunoregulation
|
|
HY-P99791-5mg
|
MedChemexpress LLC
|
Orilanolimab [CAS 2066544-85-0]
|
|
COVID-19-immunoregulation
|
|
HY-P99793-1mg
|
MedChemexpress LLC
|
Orticumab [CAS 1314241-10-5]
|
|
COVID-19-immunoregulation
|
|
HY-P99793-10mg
|
MedChemexpress LLC
|
Orticumab [CAS 1314241-10-5]
|
|
COVID-19-immunoregulation
|
|
HY-P99793-5mg
|
MedChemexpress LLC
|
Orticumab [CAS 1314241-10-5]
|
|
COVID-19-immunoregulation
|
|
HY-P99796-1mg
|
MedChemexpress LLC
|
Ozoralizumab [CAS 1167985-17-2]
|
|
COVID-19-immunoregulation
|
|
HY-P99796-10mg
|
MedChemexpress LLC
|
Ozoralizumab [CAS 1167985-17-2]
|
|
COVID-19-immunoregulation
|
|
HY-P99796-5mg
|
MedChemexpress LLC
|
Ozoralizumab [CAS 1167985-17-2]
|
|
COVID-19-immunoregulation
|
|
HY-138651-100mg
|
MedChemexpress LLC
|
PAB-Val-Lys-Boc [CAS 1432969-86-2]
|
|
COVID-19-immunoregulation
|
|
HY-138651-50mg
|
MedChemexpress LLC
|
PAB-Val-Lys-Boc [CAS 1432969-86-2]
|
|
COVID-19-immunoregulation
|
|